SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits

A Preda, F Montecucco, F Carbone… - Cardiovascular …, 2024 - academic.oup.com
An increasing number of individuals are at high risk of type 2 diabetes (T2D) and its
cardiovascular complications, including heart failure (HF), chronic kidney disease (CKD) …

Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study

J Lim, YJ Choi, BS Kim, TM Rhee, HJ Lee… - Cardiovascular …, 2023 - Springer
Background Sodium-glucose co-transporter-2 inhibitors displayed cardiovascular benefits in
type 2 diabetes mellitus in previous studies; however, there were some heterogeneities …

IL‑37 suppresses macrophage ferroptosis to attenuate diabetic atherosclerosis via the NRF2 pathway

J Xu, X Han, N **a, Q Zhao… - Experimental and …, 2023 - spandidos-publications.com
IL‑37 is a newly discovered inflammatory factor. However, the protective effect and
underlying mechanisms of IL‑37 on atherosclerosis remain unclear. In the present study, IL …

[HTML][HTML] Mitigating Vascular Inflammation by Mimicking AIBP Mechanisms: A New Therapeutic End for Atherosclerotic Cardiovascular Disease

JD Kim, A Jain, L Fang - International Journal of Molecular Sciences, 2024 - mdpi.com
Atherosclerosis, characterized by the accumulation of lipoproteins and lipids within the
vascular wall, underlies a heart attack, stroke, and peripheral artery disease. Endothelial …

Danggui Liuhuang Decoction ameliorates endothelial dysfunction by inhibiting the JAK2/STAT3 mediated inflammation

Y Xu, W Sha, J Lu, S Yu, X **, C Chen, G Ge… - Journal of …, 2025 - Elsevier
Ethnopharmacological relevance Vascular endothelial dysfunction (VED) is recognized as a
key triggering diabetic vascular complications. Danggui Liuhuang Decoction (DGLHD) has …

[HTML][HTML] Hutchinson-Gilford progeria syndrome mice display accelerated arterial thrombus formation and increased platelet reactivity

YM Puspitasari, S Ministrini, J Han, C Karch… - Thrombosis …, 2024 - Elsevier
Abstract Introduction Hutchinson-Gilford Progeria Syndrome (HGPS) is an ultra-rare
premature aging genetic disorder caused by a point mutation in the lamin A gene, LMNA …

Protective Mechanisms of SGLTi in Ischemic Heart Disease

L Liao, T Wang, L Zhang, Y Wei, X Fan - Journal of Cardiovascular …, 2024 - Springer
Ischemic heart disease (IHD) is a common clinical cardiovascular disease with high
morbidity and mortality. Sodium glucose cotransporter protein inhibitor (SGLTi) is a novel …

Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes

PA Winzap, S Kraler, S Obeid, FA Wenzl… - … Heart Journal: Acute …, 2023 - academic.oup.com
Aims Outcomes after acute coronary syndromes (ACS) are determined by baseline risk
profiles, including initial systolic blood pressure (sBP) levels. Herein, we aimed to …